Retrospective study to time the introduction of HIV type 1 non-B subtypes in Lyon, France, using env genes obtained from primary infection samples

AIDS Research and Human Retroviruses

Volumn 20, Issue 7, 2004, Pages 687-691

  Vachot, Laurence ^a   Ataman Önal, Yasemin ^a   Terrat, Céline ^a   Durand, Pierre Yves ^a   Ponceau, Bénédicte ^b   Biron, François ^b   Verrier, Bernard ^a,c  

^a University Lyon i   (France)

^b CROIX ROUSSE HOSPITAL   (France)

^c BIOMÉRIEUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; GENOMIC DNA; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; VIRUS DNA; GAG PROTEIN; VIRUS RNA;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; ENVELOPE GENE; FEMALE; FRANCE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MOLECULAR CLONING; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATIENT CODING; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; PRIMARY INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEXUAL TRANSMISSION; TRAVEL; VIRUS CHARACTERIZATION; VIRUS IDENTIFICATION; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS TRANSMISSION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLASSIFICATION; DISEASE TRANSMISSION; GENETICS; HOMOSEXUALITY; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; RISK FACTOR; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; FRANCE; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; RETROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL; VARIATION (GENETICS);

EID: 3843073102     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/0889222041524607     Document Type: Article

References (21)

1. Thomson MM and Najera R: Travel and the introduction of human immunodeficiency virus type 1 non- B subtype genetic forms into Western countries. Clin Infect Dis 2001;32:1732-1737.
2. Alvarez M, Garcia F, Martinez NM, Bernal C, Vela CM, Angulo GP, and Quero JH: Introduction of HIV type 1 non-B subtypes into Eastern Andalusia through immigration. J Med Virol 2003;70:10-13.
3. Couturier E, Damond F, Roques P, Fleury H, Barin F, Brunet JB, Brun-Vezinet F, and Simon F: HIV-1 diversity in France, 1996-1998. The AC 11 laboratory network. AIDS 2000;14:289-296.
4. Alaeus A, Leitner T, Lidman K, and Albert J: Most HIV-1 genetic subtypes have entered Sweden. AIDS 1997;11:199-202.
5. Esteves A, Parreira R, Venenno T, Franco M, Piedade J, Germano De Sousa J, and Canas-Ferreira WF: Molecular epidemiology of HIV type 1 infection in Portugal: High prevalence of non-B subtypes. AIDS Res Hum Retroviruses 2002;18:313-325.
6. Artenstein AW, Ohl CA, VanCott TC, Hegerich PA, and Mascola JR: Transmission of HIV-1 subtype E in the United States. JAMA 1996;276:99-100.
7. Apoola A, Ahmad S, and Radcliffe K: Primary HIV infection. Int J STD AIDS 2002;13:71-78.
8. Clewley JP, Arnold C, Barlow KL, Grant PR, and Parry JV: Diverse HIV-1 genetic subtypes in UK. Lancet 1996;347:1487.
9. Ataman-Önal Y, Coiffier C, Giraud A, Babic-Erceg A, Biron F, and Verrier B: Comparison of complete env gene sequences from individuals with symptomatic primary HIV type 1 infection. AIDS Res Hum Retroviruses 1999;15:1035-1039.
10. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, and Higgins DG: The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acid Res 1997;25:4876-4882.
11. Barlow KL, Tatt ID, Cane PA, Pillay D, and Clewley JP: Recombinant strains of HIV type 1 in the United Kingdom. AIDS Res Hum Retroviruses 2001;17:467-474.
12. Snoeck J, Van Dooren S, Van Laethem K, Derdelinckx I, Van Wijngaerden E, De Clercq E, and Vandamme AM: Prevalence and origin of HIV-1 group M subtypes among patients attending a Belgian hospital in 1999. Virus Res 2002;85:95-107.
13. Brodine SK, Shaffer RA, Starkey MJ, Tasker SA, Gilcrest JL, Louder MK, Barile A, VanCott TC, Vahey MT, McCutchan FE, Birx DL, Richman DD, and Mascola JR: Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion. Ann Intern Med 1999;131:502-506.
14. Mastro TD, Kunanusont C, Dondero TJ, and Wasi C: Why do HIV-1 subtypes segregate among persons with different risk behaviors in South Africa and Thailand? AIDS 1997;11:113-116.
15. Heyndrickx L, Janssens W, Coppens S, Vereecken K, Willems B, Fransen K, Colebunders R, Vandenbruaene M, and van der Groen G: HIV type 1 C2V3 env diversity among Belgian individuals. AIDS Res Hum Retroviruses 1998;14:1291-1296.
16. Barin F, Courouce AM, Pillonel J, and Buzelay L: Increasing diversity of HIV-1M serotypes in French blood donors over a 10-year period (1985-1995). Retrovirus Study Group of the French Society of Blood Transfusion. AIDS 1997;11:1503-1508.
17. Fransen K, Buve A, Nkengasong JN, Laga M, and van der Groen G: Longstanding presence in Belgians of multiple non-B HIV-1 subtypes. Lancet 1996;347:1403.
18. Engelstad M: Genetic diversity of env V3 loop sequences in HIV type 1-infected homosexuals, heterosexuals, intravenous drug users, and hemophilia patients in Norway: High prevalence of subtype B and detection of subtype C. AIDS Res Hum Retroviruses 1996;12:1733-1738.
19. Liitsola K, Holmstrom P, Laukkanen T, Brummer-Korvenkontio H, Leinikki P, and Salminen MO: Analysis of HIV-1 genetic subtypes in Finland reveals good correlation between molecular and epidemiological data. Scand J Infect Dis 2000;32:475-480.
20. Lukashov VV, Kuiken CL, Boer K, and Goudsmit J: HIV type 1 subtypes in The Netherlands circulating among women originating from AIDS-endemic regions. AIDS Res Hum Retroviruses 1996;12:951-953.
21. Lasky M, Perret JL, Peeters M, Bibollet-Ruche F, Liegeois F, Patrel D, Molinier S, Gras C, and Delaporte E: Presence of multiple non-B subtypes and divergent subtype B strains of HIV-1 in individuals infected after overseas deployment. AIDS 1997;11:43-51.